Literature DB >> 17133450

Influence of the activator in an acrylic bone cement on an array of cement properties.

Gladius Lewis1, Jie Xu, Sanjukta Deb, Blanca Vázquez Lasa, Julio San Román.   

Abstract

In all but one of the acrylic bone cement brands used in cemented arthroplasties, N,N-dimethyl-4-toluidine (DMPT) serves as the activator of the polymerization reaction. However, many concerns have been raised about this activator, all related to its toxicity. Thus, various workers have assessed a number of alternative activators, with two examples being N,N-dimethylamino-4-benzyl laurate (DMAL) and N,N-dimethylamino-4-benzyl oleate (DMAO). The results of limited characterization of cements that contain DMAL or DMAO have been reported in the literature. The present work is a comprehensive comparison of cements that contain one of these three activators, in which the values of a large array of their properties were determined. These properties range from the setting time and maximum exotherm temperature of the curing cement to the variation of the loss elastic modulus of the cured cement with frequency of the applied indenting force in dynamic nanoindentation tests. The present results, taken in conjunction with those presented in previous reports by the present authors and co-workers on other properties of these cements, indicate that both DMAL and DMPT are suitable alternatives to DMPT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133450     DOI: 10.1002/jbm.a.31067

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  2 in total

1.  Not all approved antibiotic-loaded PMMA bone cement brands are the same: ranking using the utility materials selection concept.

Authors:  Gladius Lewis
Journal:  J Mater Sci Mater Med       Date:  2015-01-17       Impact factor: 3.896

2.  A daptomycin-xylitol-loaded polymethylmethacrylate bone cement: how much xylitol should be used?

Authors:  Ali Salehi; Ashley Cox Parker; Gladius Lewis; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.